<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Anesth</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Anesth</journal-id>
      <journal-title-group>
        <journal-title>Journal of Anesthesia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0913-8668</issn>
      <issn pub-type="epub">1438-8359</issn>
      <publisher>
        <publisher-name>Springer Japan</publisher-name>
        <publisher-loc>Tokyo</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24162450</article-id>
      <article-id pub-id-type="pmc">4055844</article-id>
      <article-id pub-id-type="publisher-id">1731</article-id>
      <article-id pub-id-type="doi">10.1007/s00540-013-1731-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Preoperative morphological analysis by transesophageal echocardiography and predictive value of plasma landiolol concentration during systolic anterior motion mitral valve repair : a report of three cases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yoshimura</surname>
            <given-names>Manabu</given-names>
          </name>
          <address>
            <phone>+81-166-682583</phone>
            <fax>+81-166-682589</fax>
            <email>manabu-ygc@umin.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kunisawa</surname>
            <given-names>Takayuki</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iida</surname>
            <given-names>Takafumi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsumoto</surname>
            <given-names>Megumi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takakai</surname>
            <given-names>Hayato</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kanda</surname>
            <given-names>Hirotsugu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kurosawa</surname>
            <given-names>Atsushi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takahata</surname>
            <given-names>Osamu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iwasaki</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Anesthesiology and Critical Care Medicine, Asahikawa Medical University, Midorigaoka-higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>10</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>27</day>
        <month>10</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2014</year>
      </pub-date>
      <volume>28</volume>
      <issue>3</issue>
      <fpage>452</fpage>
      <lpage>455</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>3</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>10</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2013</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>We report three cases with systolic anterior motion (SAM) after mitral valve plasty. Preoperative mitral valve morphology is a risk factor for SAM. The morphological characteristics of SAM have been revealed in several studies. We found a small distance between coaptation and the interventricular septum in all cases, and cases 2, and 3 had a low AL/PL ratio, whereas case 3 had a large PML, which was revealed by transesophageal echocardiography. With the use of 3D transesophageal echocardiography, when mitral valve prolapse was investigated, in all three cases, it was easy to specify lesions. The issue for the future is 3D analysis when SAM is occurring.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Systolic anterior motion of the mitral valve (SAM)</kwd>
        <kwd>Transesophageal echocardiography (TEE)</kwd>
        <kwd>Mitral valve annuloplasty (MVP)</kwd>
        <kwd>Landiolol hydrochloride</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Japanese Society of Anesthesiologists 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="intro">
      <title>Introduction</title>
      <p>Systolic anterior motion (SAM) of the mitral valve has been described after mitral repair in patients with mitral regurgitation (MR) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The occurrence of SAM leads to left ventricular outflow obstruction (LVOTO), mitral regurgitation, and severe hemodynamic instability. Several studies have revealed the morphological characteristics of SAM by intraoperative transesophageal echocardiography (TEE) [<xref ref-type="bibr" rid="CR3">3</xref>] [<xref ref-type="bibr" rid="CR4">4</xref>] [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>Landiolol is an ultra-short-acting &#x3B2;1 selective adrenoceptor antagonist, with a short plasma half-life of 4&#xA0;min [<xref ref-type="bibr" rid="CR6">6</xref>], and decreases heart rate during cardiac surgery. The landiolol concentration reaches a rapid steady state level, and rapidly decreases after complete administration [<xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, it has been recommended for treating SAM [<xref ref-type="bibr" rid="CR8">8</xref>]. A population pharmacokinetic model of landiolol has been developed in healthy subjects [<xref ref-type="bibr" rid="CR9">9</xref>]. Using those parameters, we obtained plasma landiolol concentrations during perioperative anesthetic management using the Stanpump software.</p>
      <p>We here describe three patients with SAM who were treated with landiolol, and analyzed SAM morphological characteristics by TEE and predicted landiolol plasma concentration with the disappearance of SAM.</p>
    </sec>
    <sec id="Sec2">
      <title>Case 1</title>
      <p>A 65-year-old woman had fever and visual deficit, and thorough testing confirmed the presence of endocarditis, including MR and cerebral infarction. Preoperative echocardiography confirmed moderate MR due to prolapse of the posterior leaflet and vegetation (9&#xA0;&#xD7;&#xA0;4&#xA0;mm) (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a). The ejection fraction was 65&#xA0;%; thus, MVP was indicated.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>
<bold>a</bold> Preoperative 3D-TEE and 2D-TEE mid-esophageal long-axis view at the appearance of SAM in case 1. 3D-TEE indicated a vegetation and prolapse of posterior leaflet. <bold>b</bold> Preoperative 3D-TEE and 2D-TEE mid-esophageal long-axis view at the appearance of SAM in case 2. 3D-TEE indicated prolapse of posterior leaflet, P2. <bold>c</bold> Preoperative 3D-TEE and 2D-TEE mid-esophageal long-axis view at the appearance of SAM in case 3. 3D-TEE indicated prolapse of posterior leaflet</p></caption><graphic xlink:href="540_2013_1731_Fig1_HTML" id="MO1"/></fig></p>
      <p>Anesthesia was induced with target controlled infusion (TCI) of 3&#xA0;&#x3BC;g/ml propofol, 0.3&#xA0;&#x3BC;g/kg/min remifentanil, and 40&#xA0;mg rocuronium, with timely administration of phenylephrine. Preoperative transesophageal echocardiography (TEE) was performed for SAM (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). The distance from the septum to the mitral valve coaptation point (C-sept) was 2.2&#xA0;cm. Low dose landiolol (3&#xA0;&#x3BC;g/kg/min) was administered at the start of surgery. Quadrangular resection, suturing of the posterior mitral valve leaflet (PML), and vegetation resection were performed. The patient was weaned from cardiopulmonary bypass (CPB) with 5&#xA0;&#x3BC;g/kg/min dopamine, and 5&#xA0;&#x3BC;g/kg/min dobutamine.<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>
Preoperative morphological risk factor of SAM</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Risk factor</th><th align="left">Case 1</th><th align="left">Case 2</th><th align="left">Case 3</th></tr></thead><tbody><tr><td align="left">AL/PL ratio &lt;1.3</td><td char="." align="char">1.3</td><td char="." align="char">1.1*</td><td char="." align="char">0.8*</td></tr><tr><td align="left">PML &gt;15&#xA0;mm</td><td align="left">10&#xA0;mm</td><td align="left">16&#xA0;mm*</td><td align="left">27&#xA0;mm*</td></tr><tr><td align="left">AML &gt;27&#xA0;mm</td><td align="left">13&#xA0;mm</td><td align="left">18&#xA0;mm</td><td align="left">23&#xA0;mm</td></tr><tr><td align="left">Distance between coaptation and interventricular septum (C-sept) &lt;25&#xA0;mm</td><td align="left">22&#xA0;mm*</td><td align="left">23&#xA0;mm*</td><td align="left">18&#xA0;mm*</td></tr><tr><td align="left">Small angle between the aortic and mitral annular planes (&lt;120&#xB0;)</td><td align="left">143&#xB0;</td><td align="left">123&#xB0;</td><td align="left">124&#xB0;</td></tr><tr><td align="left">Small ventricle (&lt;36&#xA0;mm)</td><td align="left">44&#xA0;mm</td><td align="left">48&#xA0;mm</td><td align="left">45&#xA0;mm</td></tr><tr><td align="left">Thickening of interventricular septum</td><td align="left">(&#x2013;)</td><td align="left">(&#x2013;)</td><td align="left">(&#x2013;)</td></tr><tr><td align="left">Small angle between AML and outflow</td><td align="left">27&#xB0;</td><td align="left">25&#xB0;</td><td align="left">20&#xB0;</td></tr><tr><td align="left">Small distance between coaptation and outflow</td><td align="left">10&#xA0;mm</td><td align="left">8&#xA0;mm</td><td align="left">5&#xA0;mm</td></tr></tbody></table><table-wrap-foot><p>Asterisk indicates the risk factor of SAM</p></table-wrap-foot></table-wrap></p>
      <p>After separation from CPB, blood pressure suddenly became unstable at 74/34&#xA0;mmHg. TEE indicated SAM (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a). We stopped the administration of catecholamines and starting noradrenaline administration. A bolus of 6&#xA0;mg landiolol was initiated at 10&#xA0;&#x3BC;g/kg/min. TEE confirmed the disappearance of SAM, and hemodynamics improved. Upon disappearance of SAM, the predicted plasma landiolol concentration was 0.28&#xA0;&#x3BC;g/ml according to the Stanpump software.</p>
    </sec>
    <sec id="Sec3">
      <title>Case 2</title>
      <p>A 53-year-old woman had no complaint, but exhibited cardiac murmur; thorough testing confirmed MR. Severe MR due to prolapse of the posterior leaflet was confirmed by preoperative echocardiography (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b). The ejection fraction was 67&#xA0;%; thus, MVP was indicated.</p>
      <p>Anesthesia was induced with TCI of 3&#xA0;&#x3BC;g/ml propofol, 0.3&#xA0;&#x3BC;g/kg/min remifentanil, and 40&#xA0;mg rocuronium, with timely administration of phenylephrine. Preoperative TEE was performed in considering SAM (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). The C-sept was 2.3&#xA0;cm. Triangular resection and suturing of the PML were performed. The patient was weaned from CPB with 3&#xA0;&#x3BC;g/kg/min dopamine and 3&#xA0;&#x3BC;g/kg/min dobutamine.</p>
      <p>After separation from CPB, her blood pressure suddenly became unstable at 60/40&#xA0;mmHg. TEE indicated SAM (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b). We decreased the dose of catecholamines, and injected two boluses of 5&#xA0;mg landiolol at 10&#xA0;&#x3BC;g/kg/min. Then SAM continued, so the landiolol dose was increased to 20&#xA0;&#x3BC;g/kg/min. TEE confirmed the disappearance of SAM. Upon the disappearance of SAM, the predicted plasma landiolol concentration was 0.40&#xA0;&#x3BC;g/ml, according to the Stanpump software.</p>
    </sec>
    <sec id="Sec4">
      <title>Case 3</title>
      <p>A 55-year-old man had no complaint, but exhibited cardiac murmur; thorough testing confirmed MR. Preoperative echocardiography was confirmed to be severe MR due to prolapse of the posterior leaflet and rupture of the chordae tendineae (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>c). The ejection fraction was 62&#xA0;%; thus, MVP was indicated.</p>
      <p>Anesthesia was induced at 4&#xA0;&#x3BC;g/ml TCI of propofol, 0.4&#xA0;&#x3BC;g/kg/min remifentanil, and 50&#xA0;mg rocuronium, with timely administration of phenylephrine. Preoperative TEE was performed considering SAM (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). The C-sept was 1.8&#xA0;cm, the AL/PL ratio was 0.8, and the length of PML was 27&#xA0;mm. A quadrangular resection and suturing of the PML was performed. The patient was weaned from CPB with 2&#xA0;&#x3BC;g/kg/min dopamine and 4&#xA0;&#x3BC;g/kg/min dobutamine.</p>
      <p>After separation from CPB, blood pressure suddenly became unstable at 70/40&#xA0;mmHg. TEE indicated SAM (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>c). It showed real time 3D-TEE when SAM was occurring (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). We decreased the catecholamine dose, started noradrenaline and administered two boluses of 3&#xA0;mg landiolol at 7&#xA0;&#x3BC;g/kg/min. TEE confirmed the disappearance of SAM, and hemodynamics improved. Upon the disappearance of SAM, the predicted plasma landiolol concentration was 0.22&#xA0;&#x3BC;g/ml according to the Stanpump software.<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>It showed real time 3D-TEE when SAM is occurring in case 3</p></caption><graphic xlink:href="540_2013_1731_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec5" sec-type="discussion">
      <title>Discussion</title>
      <p>The mechanism of SAM has been reported as a Venturi or drag effect by Cape et al. and Sherrid et al. [<xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR12">12</xref>]. But its precise mechanism has not been elucidated.</p>
      <p>The appearance of SAM is a major complication following MVP and is reported to occur in from 5 to 10&#xA0;% of cases [<xref ref-type="bibr" rid="CR13">13</xref>]. The morphological characteristics of SAM have been revealed by several studies. Preoperative mitral valve morphology is a risk factor for SAM. Maslow et al. [<xref ref-type="bibr" rid="CR3">3</xref>] indicated that the pre-repair AL/PL ratio in SAM cases was &lt;1.3 and C-sept was &lt;2.5&#xA0;cm. Mihaileanu et al. [<xref ref-type="bibr" rid="CR14">14</xref>] reported that the angle between the aortic and mitral annular planes was &lt;120&#xB0;in SAM cases. Orihashi [<xref ref-type="bibr" rid="CR5">5</xref>] indicated the distance between the outflow and coaptation was small and that the angle between the anterior mitral leaflet (AML) and outflow also was small in SAM cases. Quigloey et al. [<xref ref-type="bibr" rid="CR15">15</xref>] reported that the AML was &gt;27&#xA0;mm, and that the PML should be 15&#xA0;mm in SAM cases. In our cases, measurements were performed in all three cases of SAM (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). As a result, the C-sept was &lt;2.5&#xA0;cm in all three cases. However, these morphology related reports are based on upper and lower limits, means, and experiences, without clearly setting cut-off values; it may be necessary to consider these values as references, rather than absolute standards, and combine them for the prediction of onset of SAM.</p>
      <p>TEE was useful for distinguishing SAM from residual MR. The appearance and disappearance of SAM were certainly identified by TEE (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a, b, c). Recently, 3D-TEE has been useful and provides additional information [<xref ref-type="bibr" rid="CR16">16</xref>]. Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref> shows real time 3D-TEE when SAM is occurring in Case 3. With the use of 3D-TEE, when mitral valve prolapse was investigated, in all three cases, it was easy to specify lesions. The issue for the future is 3D analysis when SAM is occurring.</p>
      <p>Treatment for SAM increases preload and afterload, specifically transfusion, and using an &#x3B1;-adrenergic agent decreases heart rate, while stopping dopamine and dobutamine. However, transfusions, starting a continuous infusion of noradrenaline, and limiting dopamine and dobutamine were insufficient in all three of our cases.</p>
      <p>Landiolol is a cardioselective ultra short-acting &#x3B2;1-adrenergic receptor blocking agent. This drug is hydrolyzed to an inactive form by both carboxyesterase in the liver and pseudocholinesterase in plasma. It has a shorter plasma half-life of approximately 4&#xA0;min compared with that of esmolol (9&#xA0;min). Landiolol has much higher cardioselectivity (&#x3B2;1/&#x3B2;2&#xA0;=&#xA0;255) than that of esmolol (&#x3B2;1/&#x3B2;2&#xA0;=&#xA0;33) [<xref ref-type="bibr" rid="CR17">17</xref>]. When patients are weaned from CPB, drugs that strictly control these effects are more desirable. Landiolol concentrations rapidly reached steady state levels and then rapidly dissipated after completing administration.</p>
      <p>It is possible to predict plasma landiolol concentrations at the disappearance of SAM. The predicted plasma landiolol concentrations in cases 1&#x2013;3 were 0.28, 0.4, and 0.22&#xA0;&#x3BC;g/ml, respectively.</p>
      <p>The cause of improvement in SAM is not only landiolol; a variety of factors have influence. We would be pleased, however, if the concentrations in our paper could serve as reference values into the future.</p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crescenzi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Landoni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zangrillo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Guarracino</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rosica</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>La Canna</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Alfieri</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Management and decision-making strategy for systolic anterior motion after mitral valve repair</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <year>2009</year>
          <volume>137</volume>
          <issue>2</issue>
          <fpage>320</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtcvs.2008.08.018</pub-id>
          <pub-id pub-id-type="pmid">19185145</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varghese</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Anyanwu</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Itagaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Milla</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Castillo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Management of systolic anterior motion after mitral valve repair: an algorithm</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <year>2012</year>
          <volume>143</volume>
          <issue>4 Suppl</issue>
          <fpage>S2</fpage>
          <lpage>S7</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtcvs.2012.01.063</pub-id>
          <pub-id pub-id-type="pmid">22423603</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maslow</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Regan</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Haering</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1999</year>
          <volume>34</volume>
          <issue>7</issue>
          <fpage>2096</fpage>
          <lpage>2104</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(99)00464-7</pub-id>
          <pub-id pub-id-type="pmid">10588230</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jebara</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Mihaileanu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Acar</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Brizard</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Grare</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Latremouille</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chauvaud</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fabiani</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Deloche</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carpentier</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Left ventricular outflow tract obstruction after mitral valve repair. Results of the sliding leaflet technique</article-title>
          <source>Circulation</source>
          <year>1993</year>
          <volume>88</volume>
          <issue>5 Pt 2</issue>
          <fpage>II30</fpage>
          <lpage>II34</lpage>
          <pub-id pub-id-type="pmid">8222170</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Orihashi K. Intraoperative imaging in aortic valve surgery as safety net. Aortic Valve Surg. Edited by Motomura N, In Tech. 2011.</mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kanamaru</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Phase 1 study of ONO-1101, a new ultra short acting &#x3B2;1-blocking agent in hearthy volunteers</article-title>
          <source>Rinsyo Iyaku</source>
          <year>2000</year>
          <volume>16</volume>
          <fpage>1531</fpage>
          <lpage>1556</lpage>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murakami</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Furuie</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsuguma</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wanibuchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kikawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Irie</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta1-selective blocker, in a dose escalation regimen in healthy male volunteers</article-title>
          <source>Drug Metab Pharmacokinet</source>
          <year>2005</year>
          <volume>20</volume>
          <issue>5</issue>
          <fpage>337</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="doi">10.2133/dmpk.20.337</pub-id>
          <pub-id pub-id-type="pmid">16272751</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Omae</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsuneyoshi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Higashi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Matsunaga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sakata</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kanmura</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>A short-acting beta-blocker, landiolol, attenuates systolic anterior motion of the mitral valve after mitral valve annuloplasty</article-title>
          <source>J Anesth</source>
          <year>2008</year>
          <volume>22</volume>
          <issue>3</issue>
          <fpage>286</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="doi">10.1007/s00540-008-0619-1</pub-id>
          <pub-id pub-id-type="pmid">18685936</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Honda</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakade</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kasai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kitagawa</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yamauchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kikawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kunisawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanigawara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Miyata</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Population pharmacokinetics of landiolol hydrochloride in healthy subjects</article-title>
          <source>Drug Metab Pharmacokinet</source>
          <year>2008</year>
          <volume>23</volume>
          <issue>6</issue>
          <fpage>447</fpage>
          <lpage>455</lpage>
          <pub-id pub-id-type="doi">10.2133/dmpk.23.447</pub-id>
          <pub-id pub-id-type="pmid">19122339</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cape</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Simons</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jimoh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weyman</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Yoganathan</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Chordal geometry determines the shape and extent of systolic anterior mitral motion: in vitro studies</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1989</year>
          <volume>13</volume>
          <issue>6</issue>
          <fpage>1438</fpage>
          <lpage>1448</lpage>
          <pub-id pub-id-type="doi">10.1016/0735-1097(89)90326-4</pub-id>
          <pub-id pub-id-type="pmid">2703621</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sherrid</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Delia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mogtader</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>EM</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1993</year>
          <volume>22</volume>
          <issue>3</issue>
          <fpage>816</fpage>
          <lpage>825</lpage>
          <pub-id pub-id-type="doi">10.1016/0735-1097(93)90196-8</pub-id>
          <pub-id pub-id-type="pmid">8354817</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sherrid</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Chaudhry</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Swistel</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction</article-title>
          <source>Ann Thorac Surg</source>
          <year>2003</year>
          <volume>75</volume>
          <issue>2</issue>
          <fpage>620</fpage>
          <lpage>632</lpage>
          <pub-id pub-id-type="doi">10.1016/S0003-4975(02)04546-0</pub-id>
          <pub-id pub-id-type="pmid">12607696</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charls</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>SAM-systolic anterior motion of the anterior mitral valve leaflet post-surgical mitral valve repair</article-title>
          <source>Heart Lung J Crit Care</source>
          <year>2003</year>
          <volume>32</volume>
          <issue>6</issue>
          <fpage>402</fpage>
          <lpage>406</lpage>
          <pub-id pub-id-type="doi">10.1016/j.hrtlng.2003.07.004</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mihaileanu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marino</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Chauvaud</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Perier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vissoat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Julien</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dreyfus</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Abastado</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Carpentier</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Left ventricular outflow obstruction after mitral valve repair (Carpentier&#x2019;s technique). Proposed mechanisms of disease</article-title>
          <source>Circulation</source>
          <year>1988</year>
          <volume>78</volume>
          <issue>3 Pt 2</issue>
          <fpage>I78</fpage>
          <lpage>I84</lpage>
          <pub-id pub-id-type="pmid">3409521</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quigley</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Prevention of systolic anterior motion after repair of the severely myxomatous mitral valve with an anterior leaflet valvuloplasty</article-title>
          <source>Ann Thorac Surg</source>
          <year>2005</year>
          <volume>80</volume>
          <issue>1</issue>
          <fpage>179</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1016/j.athoracsur.2005.01.066</pub-id>
          <pub-id pub-id-type="pmid">15975363</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jungwirth</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Mathew</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Swaminathan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Glower</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Mackensen</surname>
              <given-names>GB</given-names>
            </name>
          </person-group>
          <article-title>Mitral valve prolapse and systolic anterior motion illustrated by real time three-dimensional transesophageal echocardiography</article-title>
          <source>Anesth Analg</source>
          <year>2008</year>
          <volume>107</volume>
          <issue>6</issue>
          <fpage>1822</fpage>
          <lpage>1824</lpage>
          <pub-id pub-id-type="doi">10.1213/ane.0b013e318185d12e</pub-id>
          <pub-id pub-id-type="pmid">19020124</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iguchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iwamura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nishizaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Senokuchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sakaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hachiya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ichioka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawamura</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101</article-title>
          <source>Chem Pharm Bull</source>
          <year>1992</year>
          <volume>40</volume>
          <issue>6</issue>
          <fpage>1462</fpage>
          <lpage>1469</lpage>
          <pub-id pub-id-type="doi">10.1248/cpb.40.1462</pub-id>
          <pub-id pub-id-type="pmid">1356643</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
